Workshop to Explore Adult Immunization Strategies as a Pathway for Prevention and Wellness

PRAGUE, CZECH REPUBLIC – The rapid growth in aging populations across the globe leads to the need for more attention to the risks of disease and ways to keep us healthy and active as we age. In this context, the success of childhood vaccination programs and schedules – with regard to lives saved and costs averted – in both developed and developing countries should serve as models for both health and economic policy for adult immunization strategies. The Global Coalition on Aging (GCOA) will lead this workshop, which aims to address the role of adult immunization to advance wellness and build effective prevention strategies across the life course. Experts on the topics of aging, health policy, economics, and immunization will engage in a dialogue on the value proposition of adult immunization and the path forward.

WHO:
Michael Hodin, Executive Director, Global Coalition on Aging and Adjunct Senior Fellow, Council on Foreign Relations (Moderator)
Jane Barratt, Secretary General, International Federation on Ageing
Stephen McMahon, Governing Board Member, International Alliance of Patients’ Organizations (IAPO) and Chairman, Irish Patients Association
Prof. Roman Prymula, MD, PhD, Director, University Hospital, Hradec Kralove and Chairman of Central European Vaccine Advisory Board (CEVAG)
Michael Waldholz, Pulitzer Prize-winning journalist and author, former managing editor at Bloomberg News/ Businessweek and former bureau chief at the Wall Street Journal

WHAT:
“Adult Immunization: A Central Driver of Prevention and Wellness”

Concurrent Panel Discussion during 11th Global Conference on Ageing
International Federation on Ageing Conference
This initiative was made possible through a collaboration with Pfizer.

WHEN:  
Thursday 31 May, 11:30 – 13:00 CEST

LEARN MORE:
For the recap video, click here.
For Stephen McMahon’s reflections from the panel, read “The Prague Illumination.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.